Everardo Cobos to Male
This is a "connection" page, showing publications Everardo Cobos has written about Male.
Connection Strength
0.380
-
Loayza Pintado J, Ajani T, Hernandez D, Cobos E. A Rare Culprit or an Elusive Culprit in Disguise? Unraveling Wild-Type ATTR Cardiac Amyloidosis in Heart Failure With Reduced Ejection Fraction. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251345712.
Score: 0.059
-
Farmand D, Valdez MC, Moosavi L, Cobos E. Locus Minoris Resistentiae: Two Cases of Malignant Metastasis and Review of Literature. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:2324709621997248.
Score: 0.043
-
Jariwal R, Raza N, Bhandohal J, Cobos E. Non-Hodgkin's Plasmablastic Lymphoma as Initial Presentation of Human Immunodeficiency Virus. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:23247096211014689.
Score: 0.043
-
Civelli VF, Narang VK, Sharma R, Sharma R, Kim J, Bhandohal J, Moosavi L, Cobos E. A Progressive Case of Eosinophilic Myocarditis Due to Eosinophilic Granulomatosis With Polyangiitis in a Caucasian Male. J Investig Med High Impact Case Rep. 2020 Jan-Dec; 8:2324709620966855.
Score: 0.040
-
Moosavi L, Kim P, Uche A, Cobos E. A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619847230.
Score: 0.038
-
Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, Jenkins M, Chiriva-Internati M, Cobos E. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol. 2014 Oct; 33(5):383-401.
Score: 0.027
-
Chiriva-Internati M, Mirandola L, Yu Y, Jenkins MR, Gornati R, Bernardini G, Gioia M, Chiaramonte R, Cannon MJ, Kast WM, Cobos E. Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy. J Immunother. 2011 Jul-Aug; 34(6):490-9.
Score: 0.022
-
Li W, Frame LT, Hirsch S, Cobos E. Genistein and hematological malignancies. Cancer Lett. 2010 Oct 01; 296(1):1-8.
Score: 0.021
-
Hajeh H, Aboaid H, Fox K, Cobos E, Heidari A. What You See Is Not What You Get: Germ Cell Tumor Mimicking Disseminated Coccidioidomycosis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231191872.
Score: 0.012
-
Mann BK, D'Assumpcao C, Okumoto L, Aboaid S, Abooed A, Cobos E, Heidari A. Spurious Presentation of Pulmonary Kaposi Sarcoma as Unresolved Pneumonia Led to Fatal Outcome. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231208996.
Score: 0.012
-
Mann BK, Bhandohal JS, Cobos E, Chitturi C, Eppanapally S. LECT-2 amyloidosis: what do we know? J Investig Med. 2022 02; 70(2):348-353.
Score: 0.012
-
Thomas JS, El-Khoueiry AB, Maurer BJ, Groshen S, Pinski JK, Cobos E, Gandara DR, Lenz HJ, Kang MH, Reynolds CP, Newman EM. A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors. Cancer Chemother Pharmacol. 2021 04; 87(4):525-532.
Score: 0.011
-
Mirandola L, Figueroa JA, Phan TT, Grizzi F, Kim M, Rahman RL, Jenkins MR, Cobos E, Jumper C, Alalawi R, Chiriva-Internati M. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets. Oncotarget. 2015 Feb 20; 6(5):2812-26.
Score: 0.007
-
Zhu H, Cao M, Mirandola L, Figueroa JA, Cobos E, Chiriva-Internati M, Hermonat PL. Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice. PLoS One. 2014; 9(4):e94665.
Score: 0.007
-
Pandey A, Kurup A, Shrivastava A, Radhi S, Nguyen DD, Arentz C, D'Chuna N, Hardwick F, D'Souza MJ, Jenkins M, Grizzi F, Kast WM, Cobos E, Rahman R, Chiriva-Internati M, Chiaramonte R, Platonova N. Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability. Int Rev Immunol. 2012 Oct; 31(5):302-20.
Score: 0.006
-
Chiriva-Internati M, Pandey A, Saba R, Kim M, Saadeh C, Lukman T, Chiaramonte R, Jenkins M, Cobos E, Jumper C, Alalawi R. Cancer testis antigens: a novel target in lung cancer. Int Rev Immunol. 2012 Oct; 31(5):321-43.
Score: 0.006
-
Chiriva-Internati M, Weidanz JA, Yu Y, Frezza EE, Jenkins MR, Kennedy RC, Cobos E, Kast WM. Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer. J Immunother. 2008 Oct; 31(8):693-703.
Score: 0.005
-
Chiriva-Internati M, Cobos E, Da Silva DM, Kast WM. Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun. 2008 Apr 24; 8:8.
Score: 0.004
-
Jumper C, Cobos E, Lox C. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med. 2004 Feb; 98(2):173-7.
Score: 0.003